Mechanism for prevention of infection in preterm neonates by topical emollients: A randomized, controlled clinical trial

Pediatric Infectious Disease Journal

Volumn 33, Issue 11, 2014, Pages 1124-1127

  Darmstadt, Gary L ^a   Ahmed, Saifuddin ^b   Ahmed, A S M Nawshad Uddin ^c   Saha, Samir K ^c  

^a BILL AND MELINDA GATES FOUNDATION   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c DHAKA SHISHU HOSPITAL   (Bangladesh)

Author keywords

Neonatal; Skin barrier; Skin condition; Skin injury; Skin integrity

Indexed keywords

SUNFLOWER OIL; XIPAMIDE; EMOLLIENT AGENT; PETROLATUM; VEGETABLE OIL;

ARTICLE; BANGLADESH; BLOODSTREAM INFECTION; CONTROL GROUP; CONTROLLED STUDY; DETERIORATION; DISEASE ASSOCIATION; GESTATIONAL AGE; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFANT; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN INFECTION; NEWBORN PERIOD; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN CARE; SKIN INFECTION; TOPICAL TREATMENT; BACTEREMIA; CROSS INFECTION; INFANT, PREMATURE, DISEASES; PATHOLOGY; SKIN; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; BACTEREMIA; CROSS INFECTION; EMOLLIENTS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; PETROLATUM; PLANT OILS; SKIN; SKIN CARE;

EID: 84926108594     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000423     Document Type: Article

References (35)

1. UN Inter-agency Group for Child Mortality Estimation (IGME). Levels and Trends in Child Mortality: Report 2013. New York: UNICEF; 2013.
2. Lawn JE, Blencowe H, Oza S, et al. Every newborn: progress, priorities and potential beyond survival. Lancet 2014; 384:189-205.
3. Liu L, Johnson HL, Cousens S, et al.; Child Health Epidemiology Reference Group of WHO and UNICEF. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet. 2012;379:2151-2161.
4. Black RE, Cousens S, Johnson HL, et al.; Child Health Epidemiology Reference Group of WHO and UNICEF. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet. 2010;375:1969-1987.
5. Baqui AH, Darmstadt GL, Williams EK, et al. Rates, timing and causes of neonatal deaths in rural India: implications for neonatal health programmes. Bull World Health Organ. 2006;84:706-713.
6. Bang AT, Paul VK, Reddy HM, et al. Why do neonates die in rural Gadchiroli, India? (Part I): primary causes of death assigned by neonatologist based on prospectively observed records. J Perinatol. 2005;25(suppl 1):S29-S34.
7. Yoshio H, Tollin M, Gudmundsson GH, et al. Antimicrobial polypeptides of human vernix caseosa and amniotic fluid: implications for newborn innate defense. Pediatr Res. 2003;53:211-216.
8. Williams M. Skin of the premature infant. In: Eichenfield L, Frieden I, Esterly N, eds. Textbook of Neonatal Dermatology. Philadelphia, PA: Saunders; 2001:46-61.
9. Williams ML, Hanley K, Elias PM, et al. Ontogeny of the epidermal permeability barrier. J Investig Dermatol Symp Proc. 1998;3:75-79.
10. Kalia YN, Nonato LB, Lund CH, et al. Development of skin barrier function in premature infants. J Invest Dermatol. 1998;111:320-326.
11. Hammarlund K, Sedin G. Transepidermal water loss in newborn infants. III. Relation to gestational age. Acta Paediatr Scand. 1979;68:795-801.
12. Darmstadt GL. The skin and nutritional disorders in the newborn. Eur J Pediatr Dermatol. 1998;8:221-228.
13. Mao-Qiang M, Feingold K, Thornfeldt C, et al. Optimization of physiological lipid mixtures for barrier repair. J Invest Dermatol. 1996;106:1096-1101.
14. Darmstadt GL, Saha SK, Ahmed AS, et al. Effect of topical emollient treatment of preterm neonates in Bangladesh on invasion of pathogens into the bloodstream. Pediatr Res. 2007;61(5 pt 1):588-593.
15. Darmstadt GL, Badrawi N, Law PA, et al. Topically applied sunflower seed oil prevents invasive bacterial infections in preterm infants in Egypt: a randomized, controlled clinical trial. Pediatr Infect Dis J. 2004;23:719-725.
16. Darmstadt GL, Mao-Qiang M, Chi E, et al. Impact of topical oils on the skin barrier: possible implications for neonatal health in developing countries. Acta Paediatr. 2002;91:546-554.
17. Friedman Z, Shochat SJ, Maisels MJ, et al. Correction of essential fatty acid deficiency in newborn infants by cutaneous application of sunflower-seed oil. Pediatrics. 1976;58:650-654.
18. Lane AT, Drost SS. Effects of repeated application of emollient cream to premature neonates' skin. Pediatrics. 1993;92:415-419.
19. Nopper AJ, Horii KA, Sookdeo-Drost S, et al. Topical ointment therapy benefits premature infants. J Pediatr. 1996;128(5 pt 1):660-669.
20. Pabst RC, Starr K P, Qaiyumi S, et al. The effect of application of aquaphor on skin condition, fluid requirements, and bacterial colonization in very low birth weight infants. J Perinatol. 1999;19:278-283.
21. Salam RA, Das JK, Darmstadt GL, et al. Emollient therapy for preterm newborn infants-evidence from the developing world. BMC Public Health. 2013;13(suppl 3):S31.
22. Darmstadt GL, Saha SK, Ahmed AS, et al. Effect of skin barrier therapy on neonatal mortality rates in preterm infants in Bangladesh: a randomized, controlled, clinical trial. Pediatrics. 2008;121:522-529.
23. Darmstadt GL, Saha SK, Ahmed AS, et al. Effect of topical treatment with skin barrier-enhancing emollients on nosocomial infections in preterm infants in Bangladesh: a randomised controlled trial. Lancet. 2005;365:1039-1045.
24. LeFevre A, Shillcutt SD, Saha SK, et al. Cost-effectiveness of skin-barrierenhancing emollients among preterm infants in Bangladesh. Bull World Health Organ. 2010;88:104-112.
25. Bhutta ZA, Das JK, Bahl R, et al. Every Newborn: Can currently available interventions end preventable deaths among mothers, newborns and stillbirths and at what cost? Lancet 2014;384:347-370.
26. Darmstadt GL, Nawshad Uddin Ahmed AS, Saha SK, et al. Infection control practices reduce nosocomial infections and mortality in preterm infants in Bangladesh. J Perinatol. 2005;25:331-335.
27. National Committee for Clinical Laboratory Standards (NCCLS). Performance Standards for Antimicrobial Susceptibility Testing: Eighth Informational Supplement. Wayne, PA: NCCLS; 1998. Report No.: Document M100-S8, volume 18, no. 1.
28. Skrondal A, Rabe-Hesketh S. Generalized Latent Variable Modeling: Multilevel, Longitudinal, and Structural Equation Models. Boca Raton, FL: CRC Press;2004.
29. Brown BE, Diembeck W, Hoppe U, Elias PM. Fate of topical hydrocarbons in the skin. J Soc Cosm Chem. 1995;46:1-9
30. Ghadially R, Halkier-Sorensen L, Elias PM. Effects of petrolatum on stratum corneum structure and function. J Am Acad Dermatol. 1992;26(3 pt 2):387-396.
31. Schürer N, Schliep V, Williams ML. Differential utilization of linoleic and arachidonic acid by cultured human keratinocytes. Skin Pharmacol. 1995;8:30-40.
32. Hanley K, Kömüves LG, Bass NM, et al. Fetal epidermal differentiation and barrier development In vivo is accelerated by nuclear hormone receptor activators. J Invest Dermatol. 1999;113:788-795.
33. Hanley K, Jiang Y, Crumrine D, et al. Activators of the nuclear hormone receptors PPARalpha and FXR accelerate the development of the fetal epidermal permeability barrier. J Clin Invest. 1997;100:705-712.
34. Elias PM, Mao-Qiang M, Thornfeldt CR, Feingold KR. The epidermal permeability barrier: effects of physiologic and non-physiologic lipids. In: Hoppe U, ed. The Lanolin Book. Hamburg, Germany: Beiersdorf AG; 1999:253-279.
35. Grubauer G, Elias PM, Feingold KR. Transepidermal water loss: the signal for recovery of barrier structure and function. J Lipid Res. 1989;30:323-333.